Insights into structural dynamics of allosteric binding sites in HCV RNA-dependent RNA polymerase

References

• Akaberi, D., Bergfors, A., Kjellin, M., Kameli, N., Lidemalm, L., Kolli, B., … Lennerstrand, J. (2018). Baseline dasabuvir resistance in hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the approach. Infection Ecology & Epidemiology, 8(1), 1528117. doi: 10.1080/20008686.2018.1528117
   PubMedGoogle Scholar
• Asthana, S., Shukla, S., Ruggerone, P., & Vargiu, A. V. (2014). Molecular mechanism of viral resistance to a potent non-nucleoside inhibitor unveiled by molecular simulations. Biochemistry, 53(44), 6941–6953. doi: 10.1021/bi500490z
   PubMed Web of Science ®Google Scholar
• Asthana, S., Shukla, S., Vargiu, A. V., Ceccarelli, M., Ruggerone, P., Paglietti, G., … La Colla, P. (2013). Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole. Biochemistry, 52(21), 3752–3764. doi: 10.1021/bi400107h
   PubMed Web of Science ®Google Scholar
• Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., … Noble, W. S. (2009). MEME SUITE: Tools for motif discovery and searching. Nucleic Acids Research, 37(Web Server), W202–W208. doi: 10.1093/nar/gkp335
   PubMedGoogle Scholar
• Biswal, B. K., Cherney, M. M., Wang, M., Chan, L., Yannopoulos, C. G., Bilimoria, D., … James, M. N. G. (2005). Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. Journal of Biological Chemistry, 280(18), 18202–18210. doi: 10.1074/jbc.M413410200
   PubMed Web of Science ®Google Scholar
• Biswal, B. K., Wang, M., Cherney, M. M., Chan, L., Yannopoulos, C. G., Bilimoria, D., … James, M. N. G. (2006). Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. Journal of Molecular Biology, 361(1), 33–45. doi: 10.1016/j.jmb.2006.05.074
   PubMed Web of Science ®Google Scholar
• Bowers, K., Chow, E., Xu, H., Dror, R., Eastwood, M., Gregersen, B., … Shaw, D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In ACM/IEEE SC 2006 Conference (SC’06), Tampa, FL. doi: 10.1109/sc.2006.54
   Google Scholar
• Bressanelli, S., Tomei, L., Rey, F. A., & De Francesco, R. (2002). Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. Journal of Virology, 76(7), 3482–3492. doi: 10.1128/JVI.76.7.3482-3492.2002
   PubMed Web of Science ®Google Scholar
• Bruenn, J. A. (2003). A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Research, 31(7), 1821–1829. doi: 10.1093/nar/gkg277
   PubMed Web of Science ®Google Scholar
• Di Maio, V. C., Cento, V., Mirabelli, C., Artese, A., Costa, G., Alcaro, S., … Ceccherini-Silberstein, F. (2014). Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors. Antimicrobial Agents and Chemotherapy, 58(5), 2781–2797. doi: 10.1128/AAC.02386-13
   PubMed Web of Science ®Google Scholar
• Di Marco, S., Volpari, C., Tomei, L., Altamura, S., Harper, S., Narjes, F., … Carfí, A. (2005). Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. Journal of Biological Chemistry, 280(33), 29765–29770. doi: 10.1074/jbc.M505423200
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10-11), 647–671. doi: 10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology & Drug Design, 67(5), 370–372. doi: 10.1111/j.1747-0285.2006.00384.x
   PubMed Web of Science ®Google Scholar
• El-Hasab, M. A. E.-M., El-Bastawissy, E. E., & El-Moselhy, T. F. (2018). Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein–ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation. Journal of Biomolecular Structure and Dynamics, 36(7), 1713–1727. doi: 10.1080/07391102.2017.1332689
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. doi: 10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Hang, J. Q., Yang, Y., Harris, S. F., Leveque, V., Whittington, H. J., Rajyaguru, S., … Klumpp, K. (2009). Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus. Journal of Biological Chemistry, 284(23), 15517–15529. doi: 10.1074/jbc.M808889200
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., … Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. doi: 10.1021/acs.jctc.5b00864
   PubMed Web of Science ®Google Scholar
• Hepatitis, C. (2018). Geneva, Switzerland: World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. doi: 10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Ioakimidis, L., Thoukydidis, L., Mirza, A., Naeem, S., & Reynisson, J. (2008). Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR & Combinatorial Science, 27(4), 445–456. doi: 10.1002/qsar.200730051
   Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55(2), 351–367. doi: 10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Li, H., Tatlock, J., Linton, A., Gonzalez, J., Jewell, T., Patel, L., … Lewis, C. (2009). Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. Journal of Medicinal Chemistry, 52(5), 1255–1258. doi: 10.1021/jm8014537
   PubMed Web of Science ®Google Scholar
• Manjula, S., Sivanandam, M., & Kumaradhas, P. (2018). Probing the “fingers” domain binding pocket of hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations. Journal of Biomolecular Structure and Dynamics, 37(9), 1–45. doi: 10.1080/07391102.2018.1491419
   Web of Science ®Google Scholar
• Maynard, A., Crosby, R. M., Ellis, B., Hamatake, R., Hong, Z., Johns, B. A.,…Shotwell, J. B.  (2014). Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. Journal of Medicinal Chemistry, 57(5), 1902–1913. doi: 10.1021/jm400317w
   Google Scholar
• Meetei, P. A., Rathore, R. S., Prakash Prabhu, N., & Vindal, V. (2016). In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies. SpringerPlus, 5(1), 965. doi: 10.1186/s40064-016-2589-3
   PubMedGoogle Scholar
• Pan, D., Niu, Y., Xue, W., Bai, Q., Liu, H., & Yao, X. (2016). Computational study on the drug resistance mechanism of hepatitis C virus NS5B RNA-dependent RNA polymerase mutants to BMS-791325 by molecular dynamics simulation and binding free energy calculations. Chemometrics and Intelligent Laboratory Systems, 154, 185–193. doi: 10.1016/j.chemolab.2016.03.015
   Web of Science ®Google Scholar
• Ranjith-Kumar, C. T., Kim, Y.-C., Gutshall, L., Silverman, C., Khandekar, S., Sarisky, R. T., & Kao, C. C. (2002). Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: Role of divalent metals. Journal of Virology, 76(24), 12513–12525. doi: 10.1128/JVI.76.24.12513-12525.2002
   PubMed Web of Science ®Google Scholar
• Ryu, K., Kim, N. D., Choi, S. I., Han, C. K., Yoon, J. H., No, K. T., … Seong, B. L. (2009). Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. Bioorganic & Medicinal Chemistry, 17(8), 2975–2982. doi: 10.1016/j.bmc.2009.03.024
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. doi: 10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Sesmero, E., & Thorpe, I. (2015). Using the hepatitis C virus RNA-dependent RNA polymerase as a model to understand viral polymerase structure, function and dynamics. Viruses, 7(7), 3974–3994. doi: 10.3390/v7072808
   PubMed Web of Science ®Google Scholar
• Srivastava, M., Suri, C., Singh, M., Mathur, R., & Asthana, S. (2018). Molecular dynamics simulation reveals the possible druggable hotspots of USP7. Oncotarget, 9(76), 34289–34305. doi: 10.18632/oncotarget.26136
   Google Scholar
• Talamas, F. X., Abbot, S. C., Anand, S., Brameld, K. A., Carter, D. S., Chen, J., …Weller, P. E. (2014). Discovery of N-[4-[6-tert-Butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a Potent Inhibitor of the Hepatitis C Virus NS5B Polymerase. Journal of Medicinal Chemistry. doi: 10.1021/jm401329s
   PubMedGoogle Scholar
• Turner, P. J. (2005). XMGRACE (Version 5.1.23). Center for Coastal and Land-Margin Research. Beaverton, OR: Oregon Graduate Institute of Science and Technology.
   Google Scholar
• Venkataraman, S., Prasad, B. V. L. S., & Selvarajan, R. (2018). RNA dependent RNA polymerases: Insights from structure, function and evolution. Viruses, 10(2), 76. doi: 10.3390/v10020076
   PubMed Web of Science ®Google Scholar
• Waheed, Y., Bhatti, A., & Ashraf, M. (2013). RNA dependent RNA polymerase of HCV: A potential target for the development of antiviral drugs. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 14, 247–257. doi: 10.1016/j.meegid.2012.12.004
   PubMed Web of Science ®Google Scholar
• Wang, Z., Chen, Z., Li, J., Huang, J., Zheng, C., & Liu, J.-P. (2019). Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase. Journal of Biomolecular Structure and Dynamics, 1–12. doi: 10.1080/07391102.2019.1593244
   Web of Science ®Google Scholar
• Wu, J., Liu, W., & Gong, P. (2015). A structural overview of RNA-dependent RNA polymerases from the flaviviridae family. International Journal of Molecular Sciences, 16(6), 12943–12957. doi: 10.3390/ijms160612943
   Web of Science ®Google Scholar